GlaxoSmithKline PLC Director/PDMR Shareholding (7009R)
30 Octubre 2019 - 11:32AM
UK Regulatory
TIDMGSK
RNS Number : 7009R
GlaxoSmithKline PLC
30 October 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr Jonathan Symonds
==== ======================================== ==================================================
b) Position/status Non-Executive Chairman
==== ======================================== ==================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ==================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 July 2019 to 30 September
2019.
==== ======================================== ==================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =======================
GBP17.25 833.830
==================================================================== =======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================= ==============================
e) Date of the transaction 2019-10-30
==== ======================================== ==================================================
f) Place of the n/a
transaction
==== ======================================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr Vindi Banga
==== ======================================== ==================================================
b) Position/status Senior Independent Non-Executive Director
==== ======================================== ==================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ==================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 July 2019 to 30 September
2019.
==== ======================================== ==================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =======================
GBP17.25 416.667
==================================================================== =======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================= ==============================
e) Date of the transaction 2019-10-30
==== ======================================== ==================================================
f) Place of the n/a
transaction
==== ======================================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Dr Vivienne Cox
==== ======================================== ==================================================
b) Position/status Independent Non-Executive Director
==== ======================================== ==================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ==================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 July 2019 to 30 September
2019.
==== ======================================== ==================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =======================
GBP17.25 307.971
==================================================================== =======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================= ==============================
e) Date of the transaction 2019-10-30
==== ======================================== ==================================================
f) Place of the n/a
transaction
==== ======================================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms Lynn Elsenhans
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 July 2019 to 30 September 2019.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$44.27 1,117.592
======================= =========================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2019-10-30
==== ======================================== =====================================================
f) Place of the n/a
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Dr Laurie Glimcher
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 July 2019 to 30 September 2019.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$44.27 1,241.769
======================= =========================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2019-10-30
==== ======================================== =====================================================
f) Place of the n/a
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Dr Jesse Goodman
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 July 2019 to 30 September 2019.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$44.27 374.672
======================= =========================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2019-10-30
==== ======================================== =====================================================
f) Place of the n/a
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms Judy Lewent
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 July 2019 to 30 September 2019.
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$44.27 417.491
======================= =========================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2019-10-30
==== ======================================== =====================================================
f) Place of the n/a
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr Urs Rohner
==== ======================================== ==================================================
b) Position/status Independent Non-Executive Director
==== ======================================== ==================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ==================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 July 2019 to 30 September
2019.
==== ======================================== ==================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =======================
GBP17.25 416.667
==================================================================== =======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================= ==============================
e) Date of the transaction 2019-10-30
==== ======================================== ==================================================
f) Place of the n/a
transaction
==== ======================================== ==================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDBLFXKBFLFBK
(END) Dow Jones Newswires
October 30, 2019 13:32 ET (17:32 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
